Study: Moderna, Merck vaccines could cut melanoma's recurrence by 44 percent

Moderna vaccine
(Image credit: (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images))

There could be light at the end of the tunnel for individuals battling melanoma cancer. CBS News reported that researchers conducted a study to develop a "potential skin cancer vaccine" from Merck and Moderna, and found some promising results.

According to Reuters, a combination of Moderna's experimental melanoma vaccine and Merck's immunotherapy Keytruda "cut the risk of skin cancer's recurrence or death by 44 percent compared with Keytruda alone in a mid-stage trial."

Moderna's trial shot uses the same mRNA vaccine technology that has played an integral role in the success of COVID-19 vaccines, and the combination with Keytruda "has the capacity to be a new paradigm in the treatment of cancer," Paul Burton, Moderna's chief medical officer said in an interview.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

There were 157 melanoma patients involved in the ongoing clinical trial, and researchers noted side effects in 14.4 percent of the patients who received the drug-vaccine combo compared to 10 percent of people who were only administered Keytruda, writes Reuters.

CBS notes that the shares of both the pharmaceutical and biotech companies increased on Tuesday after researchers reported a positive outcome of the shots midway through the study.

Explore More
Kelsee Majette, The Week US

Kelsee Majette has worked as a social media editor at The Week since 2022. In 2019, she got her start in local television as a digital producer and fill-in weather reporter at NTV News. Kelsee also co-produced a lifestyle talk show while working in Nebraska and later transitioned to 13News Now as a digital content producer.